Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Orchestra BioMed Holdings Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ligand Pharmaceuticals Incorporated June 5, 202682.0%
-
Lifecore Biomedical Inc. June 4, 2026100.0%
-
Lifecore Biomedical Inc. October 29, 2025100.0%
-
Ligand Pharmaceuticals Incorporated June 9, 202580.8%
-
Orchestra BioMed Holdings Inc. June 20, 202497.4%
-
Ligand Pharmaceuticals Incorporated June 14, 202479.0%
-
Orchestra BioMed Holdings Inc. January 24, 202399.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −282 | $319.99 | $90,237 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −700 | $320.43 | $224,298 |
| Oct 30, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −50 | $317.74 | $15,887 |
| Oct 30, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −50 | $318.23 | $15,912 |
| Oct 30, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −52 | $320.24 | $16,652 |
| Oct 30, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −1,209 | $320.42 | $387,384 |
| Oct 30, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −50 | $320.49 | $16,025 |
| Jun 11, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −4,500 | $250.00 | $1,125,000 |
| Jun 10, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −500 | $250.00 | $125,000 |
| Jun 5, 2026 | Ligand Pharmaceuticals Incorporated | Grant or award | +836 | — | — |
| Jun 4, 2026 | Lifecore Biomedical Inc. | Grant or award | +25,907 | — | — |
| May 18, 2026 | Orchestra BioMed Holdings Inc. | Open-market purchase | +665 | $3.75 | $2,494 |
| May 15, 2026 | Orchestra BioMed Holdings Inc. | Open-market purchase | +8,971 | $3.90 | $34,987 |
| Dec 8, 2025 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,034 | $69.51 | $141,383 |
| Sep 23, 2025 | Ligand Pharmaceuticals Incorporated | Open-market sale | −4,418 | $170.41 | $752,871 |
Questions about Jason Aryeh
What boards is Jason Aryeh on?
Jason Aryeh sits on the boards of Lifecore Biomedical Inc., Ligand Pharmaceuticals Incorporated and Orchestra BioMed Holdings Inc.
How long has Jason Aryeh served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.